<DOC>
	<DOCNO>NCT01484301</DOCNO>
	<brief_summary>The purpose study assess impact opioid tolerability-related issue experience Canadian chronic pain patient . Approximately 170 patient enrol 16 recruiting center across Canada . Eligible patient diagnosis non-malignant , chronic pain require continuous use strong opioids ( &gt; =4 day per week ) . Recruitment initiate physician routine care appointment family pain medicine practice . Patients direct website provide consent complete anonymized , password-protected , web-based survey could complete home . This weekly online questionnaire design document chronic pain experience 12-week period . At end 12-week study , physician ask retrospectively complete information pain treatment , over-the-counter ( OTC ) medication use pain opioid-related gastrointestinal ( GI ) side effect , well co-morbid condition patient .</brief_summary>
	<brief_title>Impact Tolerability Issues Chronic Pain</brief_title>
	<detailed_description>This multi-center , non-interventional , observational study patient receive opioid treatment chronic pain . Relevant Canadian data pain severity , treatment adherence , medical resource utilization , interference activity daily live collect evaluate impact opioid-related side effect chronic pain . The focus mainly side effect gastro-intestinal ( GI ) system . The study divide 2 component : prospective , web-based patient survey physician-completed , retrospective chart review study end . The patient survey include one baseline 12 weekly follow-up survey . The purpose web survey collect accurate data patient , particularly outcomes typically record medical chart , weekly pain severity score , treatment adherence , patient-reported outcome ( PROs ) , like medical resource use impact activity daily live . To capture treatment management decision , retrospective chart review perform physician designee end 12-week period patient complete baseline least one follow-up survey . Data collect include prescribed opioid non-opioid medication pain control , GI side effect treatment , co-morbid conditions/medications , medical history . Eligible patient offer invitation letter usual care visit , study website provide via weblink . Patients nominally reimburse complete survey . This study review approved independent Ethics Committee , inform consent obtain patient . There study treatment , since non-interventional , observational study evaluate J &amp; J product ; duration study 12 week observation .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<criteria>Chronic pain nonmalignant origin ( nociceptive , neuropathic mixed pain type ) Opioid requirement &gt; =4 day per week , include new opioids ( &lt; 3 month exposure ) , opioid experience ( &gt; 3 month exposure ) , nonopioids weak opioids ( e.g. , NSAIDS Tramacet ) breakthrough adjunctive use Internet access ; read/understand English French . Current previous history opioid addiction , abuse , diversion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Chronic pain</keyword>
	<keyword>Opioids</keyword>
	<keyword>Tolerability</keyword>
</DOC>